Tag:
flibanserin
Latest Headlines
Latest Headlines
Missouri CRO fined for falsifying clinical trial work for Boehringer
PPS Clinical Research reportedly paid a $68,000 fine and pled guilty to a federal obstruction charge after acknowledging an employee at the CRO had doctored patient records for clinical trial work on
Boehringer stops female libido drug program
Following a disastrous expert panel review and a complete response letter from the FDA, Boehringer Ingelheim said it's halting development of its female desire drug flibanserin. In June the
FDA experts unanimously reject Boehringer's female libido pill
Undercut by a harsh regulatory assessment on both safety and efficacy, Boehringer Ingelheim's female libido pill was handed a decisive rejection by an expert FDA panel on Friday. The experts voted
FDA staffers raise doubts about Boehringer's female libido drug
Just ahead of a June 18 FDA panel review, the FDA has released a staff review of Boehringer Ingelheim's sexual desire drug flibanserin , saying it may not be either safe or effective. Unlike male sex
FDA panel review looms for controversial libido drug
The first time researchers studied flibanserin, they thought they had a potential new depression therapy on their hands. That approach failed. But now Boehringer Ingelheim is preparing to make the
Boehringer bets on female libido drug
Germany's Boehringer Ingelheim has high hopes for its experimental female libido booster flibanserin. The treatment, which addresses hypoactive sexual desire disorder, or HSDD, has completed Phase
